Mr. Jeff Zanini of Blox Labs reports

BLOX LABS INC. AND CANNVAS MEDTECH INC. SIGN LOI FOR CANNABLOX DATA ANALYTICS

Blox Labs Inc. has signed a letter of intent with Cannvas Medtech Inc., a leading business technology company in the cannabis space, to negotiate, in good faith, a data analytics agreement with respect to CannaBLOX, a blockchain-based smart contract supply chain management platform for the legalized cannabis industry that Blox Labs is developing in partnership with Liberty Leaf Holdings Ltd.

Under the terms of the agreement, the parties will assess, amongst other endeavours, various synergies that may exist through the utilization of Cannvas Data's analytical modelling framework and the various data capture opportunities that the CannaBLOX platform would provide. Cannvas will develop specific parameters within its existing Cannvas Data framework to collect and analyze transactional and industry data from the CannaBLOX platform and its strategic industry partners. CannaBLOX would, in turn, gain access to a broad industry-level dataset as it rolls out its preliminary module during a beta test phase.

Analytics from CannaBLOX will provide Cannvas Data with the additional insights of supply chain management, dissemination of cannabis products and their volumes within Canada, and various other transactional information from its seed-to-sale solution. The company's mission with Cannvas Data is to share and analyze data from its credible source to enhance its continuing smart contract and blockchain applications currently with CannaBLOX. Cannvas Data will continue to leverage existing partnership databases, site traffic and contextual technology for user engagement purposes to further its analytical solutions for the global cannabis community. The parties have agreed to a discovery period, whereby the technological specifications of the integration will be set up by Cannvas Data, and will work together toward a definitive partnership agreement within the next 60 days.

Jeff Zanini, chief executive officer of Blox Labs, commented: "This partnership is most synergistic with our recent platform announced last week, AiBLOX, which is key in capturing analytics through machine learning (ML) and artificial intelligence (AI) data. The partnership with Cannvas Medtech, who are a leader in the data space for medical marijuana, will push our project forward on many fronts."

Shawn Moniz, chief executive officer of Cannvas Medtech, commented: "Performing analytics on a variety of datasets is our bread and butter with Cannvas Data. Infusing our existing data with data points provided from a seed-to-sale platform further enriches our ability to provide end-to-end customer behavioural analytics, industry trend analysis and much more now that we can analyze the pre and post customer journey. We are excited to partner with Blox Labs to explore how best to analyze our cannabis industry data together."

About Blox Labs Inc.

Blox Labs is a technology development company focused on creating best-in-class software solutions driven by emerging trends in blockchain, smart contracts and decentralized applications. Blox Labs is helping customers with solutions for business problems from proofs of concept through execution. The company is currently piloting blockchain solutions for supply chain management and improvement, as well as other areas. Blox Labs is actively targeting partnerships and strategic acquisitions of growth companies.

We seek Safe Harbor.